\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\\.\ \(1\)\
\-\ patient\\ had\\ an\\ immediate\\ post\\-op\\ mr\\ to\\ confirm\\ resolution\\ of\\ the\\ mass\\ effect\\.\\ \\ these\\ tumors\\ are\\ less\\ aggressive\\ and\\ have\\ a\\ good\\ surgical\\ cure\\ rate\\ but\\ recurrence\\ is\\ possible\\ so\\ he\\ will\\ need\\ survellience\\ mr\\ imaging\\.\ \(0\)\
\-\ ct\\-\\ within\\ the\\ posterior\\ right\\ frontal\\-parietal\\ region\\ there\\ is\\ a\\ large\\ heterogeneous\\ cystic\\ mass\\ measuring\\ \\~7\\.0\\ x\\ 5\\.0\\ cm\\.\\ \\ there\\ is\\ a\\ 3\\.0\\ x\\ 2\\.0\\ cm\\ isodense\\ mural\\ nodule\\ that\\ is\\ abutting\\ the\\ peripheral\\ leptomeninges\\,\\ and\\ shows\\ diffuse\\ enhancement\\.\\ \\ there\\ is\\ a\\ 5mm\\ focus\\ of\\ calcification\\ within\\ the\\ mural\\ nodule\\.\\ \\ there\\ is\\ associated\\ mass\\ effect\\ and\\ 1\\.2\\ cm\\ of\\ right\\ to\\ left\\ midline\\ shift\\.\\ \ \(0\)\
\-\ mr\\-\\ there\\ is\\ a\\ large\\ heterogeneous\\ cystic\\ mass\\ in\\ the\\ right\\ posterior\\ frontal\\-parietal\\ region\\.\\ \\ there\\ is\\ a\\ heterogeneous\\ mural\\ nodule\\ that\\ abuts\\ the\\ peripheral\\ leptomeninges\\,\\ and\\ demonstrates\\ avid\\ enhancement\\ after\\ gadolinium\\-dtpa\\ administration\\.\\ \\ again\\ identified\\ is\\ the\\ significant\\ mass\\ effect\\ and\\ associated\\ midline\\ shift\\ to\\ the\\ left\\.\ \(0\)\
\-\ pleomorphic\\ xanthoastrocytoma\ \(2\)\
\-\ pleomorphic\\ xanthoastrocytoma\ \(2\)\
\-\ pilocytic\\ astrocytoma\ \(31\)\
\-\ ganglioglioma\ \(14\)\
\-\ pnet\ \(0\)\
\-\ parasitic\\ cyst\\ \\(e\\.g\\.\\ racemose\\ cysticercosis\\)\ \(0\)\
\-\ 19\\ y\\.o\\ male\\ with\\ new\\ onset\\ emesis\\.\ \(1\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mural\\:\\ 0\\.26596545738881655\ \(0\)\
\-\ leptomeninges\\:\\ 0\\.23183488261892982\ \(0\)\
\-\ is\\:\\ 0\\.21392219928418302\ \(0\)\
\-\ there\\:\\ 0\\.2072104376122333\ \(0\)\
\-\ xanthoastrocytoma\\:\\ 0\\.2060509764578296\ \(0\)\
\-\ nodule\\:\\ 0\\.2055198650421042\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.18845874344478078\ \(0\)\
\-\ effect\\:\\ 0\\.1826546031313999\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.175664999036651\ \(0\)\
\-\ mr\\:\\ 0\\.16847907026865758\ \(0\)\
\-\ mass\\:\\ 0\\.16576500162155458\ \(0\)\
\-\ shift\\:\\ 0\\.15250812087573698\ \(0\)\
\-\ cm\\:\\ 0\\.14954037828976913\ \(0\)\
\-\ the\\:\\ 0\\.13854842252168326\ \(0\)\
\-\ survellience\\:\\ 0\\.13263323718407344\ \(0\)\
\-\ midline\\:\\ 0\\.1305544099832111\ \(0\)\
\-\ peripheral\\:\\ 0\\.12412989036748392\ \(0\)\
\-\ racemose\\:\\ 0\\.1220867442121559\ \(0\)\
\-\ cure\\:\\ 0\\.11032237157830241\ \(0\)\
\-\ abuts\\:\\ 0\\.10624063493046115\ \(0\)\
\-\ cystic\\:\\ 0\\.10454617635268544\ \(0\)\
\-\ region\\:\\ 0\\.1038325248073206\ \(0\)\
\-\ abutting\\:\\ 0\\.10164131868109312\ \(0\)\
\-\ enhancement\\:\\ 0\\.09991425905495928\ \(0\)\
\-\ avid\\:\\ 0\\.09811437063586004\ \(0\)\
\-\ isodense\\:\\ 0\\.09709963648968697\ \(0\)\
\-\ cysticercosis\\:\\ 0\\.09569414195854362\ \(0\)\
\-\ parasitic\\:\\ 0\\.09440756975054405\ \(0\)\
\-\ pnet\\:\\ 0\\.09322135580890188\ \(0\)\
\-\ 5mm\\:\\ 0\\.09247899525699725\ \(0\)\
\-\ associated\\:\\ 0\\.09149391900193862\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.09109482570917557\ \(0\)\
\-\ posterior\\:\\ 0\\.08976387725226977\ \(0\)\
\-\ and\\:\\ 0\\.08967461260681932\ \(0\)\
\-\ emesis\\:\\ 0\\.0881018051877707\ \(0\)\
\-\ large\\:\\ 0\\.08697622930685502\ \(0\)\
\-\ right\\:\\ 0\\.08632743076525307\ \(0\)\
\-\ pilocytic\\:\\ 0\\.08325641285073573\ \(0\)\
\-\ immediate\\:\\ 0\\.08306008273177634\ \(0\)\
\-\ confirm\\:\\ 0\\.08122468289014176\ \(0\)\
\-\ within\\:\\ 0\\.07994930241767174\ \(0\)\
\-\ need\\:\\ 0\\.07990077232448574\ \(0\)\
\-\ again\\:\\ 0\\.07742006356435031\ \(0\)\
\-\ that\\:\\ 0\\.07533070333381045\ \(0\)\
\-\ aggressive\\:\\ 0\\.07505537998745077\ \(0\)\
\-\ focus\\:\\ 0\\.0735215988791337\ \(0\)\
\-\ so\\:\\ 0\\.07300924834749539\ \(0\)\
\-\ recurrence\\:\\ 0\\.0716601675972584\ \(0\)\
\-\ good\\:\\ 0\\.0705919836076792\ \(0\)\
\-\ resolution\\:\\ 0\\.07042102256063885\ \(0\)\
\-\ administration\\:\\ 0\\.06911837736966642\ \(0\)\
\-\ 19\\:\\ 0\\.06873315747487442\ \(0\)\
\-\ measuring\\:\\ 0\\.06714528090401799\ \(0\)\
\-\ rate\\:\\ 0\\.06577005368563933\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.06552163391255447\ \(0\)\
\-\ to\\:\\ 0\\.06509500681117722\ \(0\)\
\-\ tumors\\:\\ 0\\.06383253686264949\ \(0\)\
\-\ calcification\\:\\ 0\\.061967096787941246\ \(0\)\
\-\ identified\\:\\ 0\\.0615344029915796\ \(0\)\
\-\ factoid\\:\\ 0\\.060614765236899376\ \(0\)\
\-\ new\\:\\ 0\\.060045490635761645\ \(0\)\
\-\ contributory\\:\\ 0\\.0593318112857698\ \(0\)\
\-\ left\\:\\ 0\\.05921466938336813\ \(0\)\
\-\ less\\:\\ 0\\.0590474035077802\ \(0\)\
\-\ possible\\:\\ 0\\.05880778638065064\ \(0\)\
\-\ will\\:\\ 0\\.05586295618231673\ \(0\)\
\-\ onset\\:\\ 0\\.05573290946662723\ \(0\)\
\-\ diffuse\\:\\ 0\\.05443059631142408\ \(0\)\
\-\ see\\:\\ 0\\.05399123836146614\ \(0\)\
\-\ he\\:\\ 0\\.05139623972257214\ \(0\)\
\-\ of\\:\\ 0\\.05095561920356167\ \(0\)\
\-\ shows\\:\\ 0\\.050940583782099376\ \(0\)\
\-\ significant\\:\\ 0\\.05011295768068106\ \(0\)\
\-\ cyst\\:\\ 0\\.05006827226498183\ \(0\)\
\-\ these\\:\\ 0\\.049012571831231595\ \(0\)\
\-\ imaging\\:\\ 0\\.04561319711763497\ \(0\)\
\-\ demonstrates\\:\\ 0\\.043604374039380764\ \(0\)\
\-\ have\\:\\ 0\\.043358375963065895\ \(0\)\
\-\ had\\:\\ 0\\.043243974122539754\ \(0\)\
\-\ but\\:\\ 0\\.04291978068026005\ \(0\)\
\-\ surgical\\:\\ 0\\.0421847270680607\ \(0\)\
\-\ after\\:\\ 0\\.04210520403106652\ \(0\)\
\-\ non\\:\\ 0\\.041182000206608234\ \(0\)\
\-\ male\\:\\ 0\\.03864403846821287\ \(0\)\
\-\ an\\:\\ 0\\.03318974357594955\ \(0\)\
\-\ are\\:\\ 0\\.0329343848808459\ \(0\)\
\-\ patient\\:\\ 0\\.028229738969961563\ \(0\)\
\-\ in\\:\\ 0\\.021591536440822998\ \(0\)\
\-\ with\\:\\ 0\\.01699535505796458\ \(0\)\
